PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0062
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Kimia Farma (KAEF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kimia Farma (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
PT Kimia Farma – Key Facts
PT Kimia Farma – Key Employees
PT Kimia Farma – Major Products and Services
PT Kimia Farma – History
PT Kimia Farma – Company Statement
PT Kimia Farma – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
PT Kimia Farma – Business Description
Business Segment: Distribution Segment
Overview
Performance
Business Segment: Manufacturing Segment
Overview
Performance
Business Segment: Other Segment
Performance
Business Segment: Retail Segment
Overview
Performance
R&D Overview
PT Kimia Farma – Corporate Strategy
PT Kimia Farma – SWOT Analysis
SWOT Analysis – Overview
PT Kimia Farma – Strengths
PT Kimia Farma – Weaknesses
PT Kimia Farma – Opportunities
PT Kimia Farma – Threats
PT Kimia Farma – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PT Kimia Farma, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
PT Kimia Farma, Key Facts
PT Kimia Farma, Key Employees
PT Kimia Farma, Major Products and Services
PT Kimia Farma, History
PT Kimia Farma, Other Locations
PT Kimia Farma, Subsidiaries
PT Kimia Farma, Joint Venture
PT Kimia Farma, Key Competitors
PT Kimia Farma, Ratios based on current share price
PT Kimia Farma, Annual Ratios
PT Kimia Farma, Annual Ratios (Cont...1)
PT Kimia Farma, Annual Ratios (Cont...2)
PT Kimia Farma, Interim Ratios
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PT Kimia Farma, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
PT Kimia Farma, Performance Chart (2014 - 2018)
PT Kimia Farma, Ratio Charts
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hutchison China Meditech Ltd
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Intermountain Rural Electric Association:発電所・企業SWOT分析
    Intermountain Rural Electric Association - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informa …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Valero Energy Corp (VLO):企業の財務・戦略的SWOT分析
    Valero Energy Corp (VLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EnCana Corporation (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Pendopharm-製薬・医療分野:企業M&A・提携分析
    Summary PendoPharm is a healthcare company that offers production and commercialization of a wide range of drugs. The company’s products comprise spans prescription drugs, over-the-counter and behind-the-counter products. Its prescription products offers drugs for therapeutic areas of gastroenterolo …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • Building Energy SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Building Energy SpA (Building Energy) is a renewable energy company that operates and develops renewable energy projects such as biomass, hydro, wind and solar projects. The company provides operation and maintenance services such as real time performance monitoring, performance guarantee, p …
  • Sturm, Ruger & Company, Inc.:企業の戦略・SWOT・財務情報
    Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Braxton Technologies LLC:企業の戦略・SWOT・財務分析
    Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report Summary Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Spero Therapeutics Inc (SPRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Spero Therapeutics Inc. (Spero) is a clinical-stage biopharmaceutical company. It is engaged in developing, identifying and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections. Its product pipeline includes SPR994 oral gram-negative program, SPR741and SPR206 …
  • Cypress Energy Partners LP (CELP):企業の財務・戦略的SWOT分析
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • T2 Biosystems Inc (TTOO):医療機器:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Guangzhou Pharmaceuticals Corp:企業の戦略的SWOT分析
    Guangzhou Pharmaceuticals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Goldcorp Inc:企業のM&A・事業提携・投資動向
    Goldcorp Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goldcorp Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆